Balancing The Scales: The Ups And Downs Of Bioprocess Scale-Up
Dry Powder Inhalable Vaccines For Shelf Stability And Global Access
Navigating Your Holistic Approach To CCI For Biologic Drug Products
Accelerating Drug Development For Biologics: Flexible And Fast DNA-To-IND Programs
Leveraging Platforms To Create Vaccines At Pandemic Speed
Accelerate Your Bispecific Antibody Development
How Does bYlok Technology Work? How Can It Improve Bispecific Production?
Solving Bispecific Antibody Heavy-Light Chain Mispairing
Scalable Protein Expression With Pichia Pastoris
Process Intensification To Improve Efficiency, Productivity
Development, Manufacture Of Biopharmaceuticals In Microbial Systems
Identifying And Mitigating Potential For Immunogenicity, Immunotoxicity
Addressing Key Challenges Of High Concentration Formulation Development
Reaching BLA Success: Fast-Track Approach To Process Characterization
Hybrid Approach For Optimizing Transient Protein Expression In CHO Cells
Trends, Challenges, And Opportunities In Bispecific Antibodies
Our Biotech Success — Levicept
Challenges Of Moving A Bioconjugate Candidate From Clinic To Market
Precision Execution Of Bispecifics At Scale From Design To Delivery
In Silico, In Vitro Tools For Regulatory Submission, Feedback
Optimizing The Path To First-In-Human Clinical Trials: Design And De-Risk
Challenges Associated With In-Use Simulated Administration Of Biologics
Drug Product Process Characterization For Liquid And Lyophilized DP
Early Developability And Analytical Toolbox For The Production Of Multi-Chain Biotherapeutics
Embrace Molecule Complexity With Optimized Expression Technologies
Achieving Biologics License Application Success Using A Structured Approach
Mitigate Risk Of Failure In Biotherapeutic Development
Pionyr: Selecting A CDMO To Scale-Up Manufacturing
Our Biotech Success — Surrozen
Expressing Next-Gen Immunotherapies And Other Advanced Biologics
Overcoming The Challenges In Fabs And Fc-Fusion Development Programs
Improved Design And Production Of Bispecific Therapeutics
Key Enablers For Late Phase Biologic Drug Development, Launch
Predictive Modeling Of Concentration-Dependent Viscosity Behavior
DNA To IND In 11 Months: Integrated Drug Substance, Drug Product Offering
Developing A mAb For A Small Biotech Developing Precision Medicines
Analytical Strategies To Address Common Development Challenges
How To Bring (Any) mRNA To Life: Simplifying Nucleic Acid Encapsulation
Filling The Need For Integrated Bioconjugate Solutions
CMC Strategy To Take Bispecifics From DNA To IND In 13 Months
Overcome Manufacturability, Expression, Early Material Generation Challenges
Best Tech Transfer Practices To Optimize Clinical And Commercial Supply
Effective Technology Transfer For Mammalian Derived Biopharmaceuticals
Particle Investigation: Going One Step Further Than Just The Identification
Deciphering mRNA Immunogenicity: Early Assessment Of Human Immune Response
Inclusion Bodies: Mother Nature's Help Or Hindrance?
Early Development To Clinic – De-Risking A Bioconjugate's Journey
Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats
Harnessing New Tech To Create Next-Generation GS-CHO Expression Solutions
How To Design An HPAPI Plant And Its Containment Systems
Simultaneous Spray Drying: Dry Powder Inhaler Combination Formulations
How To Safely Handle Your Antibody Drug Conjugate
Local Delivery For Treatment Of Lung Cancer
Meeting The Challenge Of Rising API Complexity
Identify And Mitigate Absorption Risks With PBPK Modeling
Environmental Sustainability: Use Case - Solvent Recovery
Rapid Development Of Amorphous Solid Dispersions For Bioavailability
Chromatography, Purification & Isolation Technologies
Increase Spray Drying Throughput For Brick Dust Compounds
Pharmaceutical Spray Drying: Sustainable Commercial Best Practices
From Powder To Particles With Jet Milling
Dramatic Reduction Of Solvent Usage In Pharmaceutical Spray Drying
Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion
PBPK Modeling: Mitigating Absorption Risks In Early Drug Development
How To Deal With The Complexity Of Drugs In Clinical Development
Continuous Flow Techniques For Fine Chemical Manufacturing
Particle Size Control Through Micronization: Challenges And Solutions
Streamlined Selection Of In Vivo Predictive Dissolution Media
Solid Form Screening Of Active Pharmaceutical Ingredients
Process Re-Design For Sustainability In Small Molecule Manufacturing
Environmental Sustainability: Wastewater Incineration Reduction
An End-To-End Industrialization Roadmap For Autologous Cell Therapy
The CDMO Value Proposition For Your Autologous Cell Therapy
Scalable Suspension LVV Production Platforms
De-Risk Your Path To Clinic With An AAV Suspension Platform
Improved And Rebalanced Plasmids To Ramp Up Your AAV Productivity
Keys To A Successful cGMP Manufacturing Operation Delivering CGTs
Secure And Industrialize Your CGT Process Towards cGMP Manufacturing
Preparing For FDA Pre-Approval Inspection: Quality And Regulatory Topics
Scale-Up Allogeneic Cell Therapies To Large Patient Populations
Path To IND: AAV Transient Transfection, Producer Cell Line Platforms
